Richard H. Tullis
Nessuna posizione attualmente
Profilo
Richard H.
Tullis was the founder of Synthetic Genetics (1985) where he held the title of President & Chief Executive Officer.
He is also the founder of Molecular Biosystems, Inc. Dr. Tullis's former jobs include Interim Chief Executive Officer at Genetic Vectors, Inc. and Director at Verthermia, Inc. He was also the Chief Scientific Officer at Aethlon Medical, Inc. from 2000 to 2016.
Dr. Tullis earned a doctorate degree from the University of California San Diego.
Precedenti posizioni note di Richard H. Tullis
Società | Posizione | Fine |
---|---|---|
AETHLON MEDICAL, INC. | Direttore Tecnico/Scientifico/R&S | 09/02/2016 |
Verthermia, Inc.
Verthermia, Inc. Miscellaneous Commercial ServicesCommercial Services Verthermia, Inc. develops cancer treatment which induces Whole Body Hyperthermia (WBHT) by directly heating circulating blood. It specializes in medical devices and cancer therapy. The company was founded in 2012 and is headquartered in San Jose, CA. | Direttore/Membro del Consiglio | - |
Genetic Vectors, Inc.
Genetic Vectors, Inc. Pharmaceuticals: MajorHealth Technology Genetic Vectors, Inc. is a biotechnology company, which supplies genetic engineering tools and analytical kits to the biotechnology and molecular biology markets. Its products allow biopharmaceutical companies to test for biopharmaceutical product purity in compliance with regulatory standards. The company is currently marketing the EpiDNA product line as a quality control tool for the biopharmaceutical industry. Its EasyID genetic screening products are designed to study disease risk assessment, drug resistance, and drug responsiveness. The company was founded by Mead M. McCabe on December 28, 1991 and is headquartered in Aventura, FL. | Presidente | - |
Synthetic Genetics
Synthetic Genetics Miscellaneous Commercial ServicesCommercial Services Part of Ngen, Inc., Synthetic Genetics is an American company that provides a broad line of modified obligonucleotides, including research probes to the research market. The company was founded by Richard H. Tullis. Synthetic Genetics was acquired by Epoch Biosciences, Inc., a subsidiary of Ngen, Inc. from Immune Complex Corp. on November 21, 2000 for $3.10 million. | Fondatore | - |
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Fondatore | - |
Formazione di Richard H. Tullis
University of California San Diego | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AETHLON MEDICAL, INC. | Health Technology |
Aziende private | 4 |
---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Health Technology |
Synthetic Genetics
Synthetic Genetics Miscellaneous Commercial ServicesCommercial Services Part of Ngen, Inc., Synthetic Genetics is an American company that provides a broad line of modified obligonucleotides, including research probes to the research market. The company was founded by Richard H. Tullis. Synthetic Genetics was acquired by Epoch Biosciences, Inc., a subsidiary of Ngen, Inc. from Immune Complex Corp. on November 21, 2000 for $3.10 million. | Commercial Services |
Genetic Vectors, Inc.
Genetic Vectors, Inc. Pharmaceuticals: MajorHealth Technology Genetic Vectors, Inc. is a biotechnology company, which supplies genetic engineering tools and analytical kits to the biotechnology and molecular biology markets. Its products allow biopharmaceutical companies to test for biopharmaceutical product purity in compliance with regulatory standards. The company is currently marketing the EpiDNA product line as a quality control tool for the biopharmaceutical industry. Its EasyID genetic screening products are designed to study disease risk assessment, drug resistance, and drug responsiveness. The company was founded by Mead M. McCabe on December 28, 1991 and is headquartered in Aventura, FL. | Health Technology |
Verthermia, Inc.
Verthermia, Inc. Miscellaneous Commercial ServicesCommercial Services Verthermia, Inc. develops cancer treatment which induces Whole Body Hyperthermia (WBHT) by directly heating circulating blood. It specializes in medical devices and cancer therapy. The company was founded in 2012 and is headquartered in San Jose, CA. | Commercial Services |
- Borsa valori
- Insiders
- Richard H. Tullis